Trials / Completed
CompletedNCT00153491
Adherence to Lumefantrine-Artemether
Assessment of Adherence to a 6-Dose Regimen of Coartem for Treatment of Uncomplicated Malaria in Children Under 5 Years in Tanzania
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (planned)
- Sponsor
- Centers for Disease Control and Prevention · Federal
- Sex
- All
- Age
- 0 Years – 59 Months
- Healthy volunteers
- Not accepted
Summary
This is a study of how well caregivers of children with malaria adhere to the recommended regimen for lumefantrine-artemether (LA). Children were randomly assigned to either a group receiving directly observed treatment in hospital or to a group treated at home by the routine caregiver (typically, patient's mother). Clinical/parasitologic, hematologic, pharmacologic and qualitative parameters were monitored over a 28-day follow-up period and are used to evaluate drug adherence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | artemether-lumefantrine |
Timeline
- Start date
- 2002-08-01
- Completion
- 2006-08-01
- First posted
- 2005-09-12
- Last updated
- 2005-09-12
Locations
1 site across 1 country: Tanzania
Source: ClinicalTrials.gov record NCT00153491. Inclusion in this directory is not an endorsement.